Association of increased tumor-infiltrating lymphocytes (TILs) with immunomodulatory (IM) triple-negative breast cancer (TNBC) subtype and response to neoadjuvant platinum-based therapy in PrECOG0105.
Shaveta Vinayak
No relevant relationships to disclose
Robert James Gray
No relevant relationships to disclose
Sylvia Adams
No relevant relationships to disclose
Kristin C. Jensen
No relevant relationships to disclose
Judith Manola
Research Funding - Sanofi
Anosheh Afghahi
No relevant relationships to disclose
Lori J. Goldstein
No relevant relationships to disclose
James M. Ford
Research Funding - Myriad Genetics; Sanofi
Sunil S. Badve
No relevant relationships to disclose
Melinda L. Telli
Consultant or Advisory Role - Myriad Genetics (U); Sanofi (U)
Research Funding - Sanofi